BioCardia, Inc. is a clinical-stage biotherapeutic company, which engages in the business of developing cellular and cell-derived therapeutics for the treatment of cardiovascular and pulmonary diseases with significant unmet medical needs. Its pipeline includes CardiAMP, CardiALLO, PulmALLO, Helix Biotherapeutic Delivery System, and Morph DNA and Avance Steerable Introducers. The company was founded on January 12, 1994 and is headquartered in Sunnyvale, CA.
Sector:
Health Technology
Industry:
Biotechnology
Employees:
20
Frequently Asked Questions
What is Market Cap of BioCardia Inc.?
Market cap, also known as market capitalization, is the total market value of a company. It’s calculated by multiplying the current market price by the total number of shares outstanding. BioCardia Inc. market cap is $12.41M.
What is the 52-week high for BioCardia Inc.?
52 week high is the highest price of a stock in the past 52 weeks, or one year. BioCardia Inc. 52 week high is $3.25 as of September 16, 2025.
What is the 52-week low for BioCardia Inc.?
52 week low is the lowest price of a stock in the past 52 weeks, or one year. BioCardia Inc. 52 week low is $1.63 as of September 16, 2025.
What is BioCardia Inc. stock price today?
BioCardia Inc. stock price today is $2.15.
What was BioCardia Inc. stock price yesterday?
BioCardia Inc. stock price yesterday was $2.14.
What is the PE ratio of BioCardia Inc.?
The Price-to-Earnings (or P/E) ratio is a commonly used tool for valuing a company. It’s calculated by dividing the current share price by the earnings per share (or EPS). It can also be calculated by dividing the company’s Market Cap by the Net Profit. BioCardia Inc.’s P/E ratio is -1.02.
What is the Price-to-Book ratio of BioCardia Inc.?
The Price-to-Book (P/B) ratio is a commonly used tool for valuing a company. It’s calculated by dividing a company’s market capitalization by its book value. BioCardia Inc. P/B ratio is -6.2462.
What is the 50-day moving average of BioCardia Inc.?
The 50-day moving average is a frequently used data point by active investors and traders to understand the trend of a stock. It’s calculated by averaging the closing stock price over the previous 50 trading days. BioCardia Inc. 50-day moving average is $2.07.
